Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c337 |
|---|---|
| Identifier | NCT06753890 |
| Trial Title | Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Diarrhea-predominant Irritable Boewl Syndrome |
| Interventions | DRUG: Changkang granules|DRUG: Changkang Granules placebo |
Participant Information
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
|---|---|
| City | Baoding |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-12-30 |
|---|---|
| Primary Completion Date | 2026-11-11 |
| Completion Date | 2026-12-30 |